Brand Name | Generic Name | Sponsor | Designated | Exclusivity End | Designation Status |
|---|
resminostat mesilate | resminostat mesilate | 4SC AG | 2023 | — | Designated |
a ligand binding moiety to STAT3, a chemical linker, and a ligand binding moiety to an E3 ligase that leads to STAT3 degradation | a ligand binding moiety to STAT3, a chemical linker, and a ligand binding moiety to an E3 ligase that leads to STAT3 degradation | Kymera Therapeutics | 2022 | — | Designated |
PEGylated 24-amino acid peptide inhibitor of Interleukin-2, Interleukin-9 and Interleukin-15 | PEGylated 24-amino acid peptide inhibitor of Interleukin-2, Interleukin-9 and Interleukin-15 | Equillium, Inc. | 2019 | — | Withdrawn |
tenalisib | tenalisib | Rhizen Pharmaceuticals SA | 2018 | — | Designated |
1-118-signal regulatory protein alpha (human) fusion protein with immunoglobulin G1 (human Fc fragment), dimer | 1-118-signal regulatory protein alpha (human) fusion protein with immunoglobulin G1 (human Fc fragment), dimer | Trillium Therapeutics Inc. | 2018 | — | Withdrawn |
fenretinide | fenretinide | SciTech Development, LLC | 2017 | — | Designated |
lacutamab | lacutamab | Innate Pharma | 2017 | — | Designated |
resiquimod | resiquimod | Galderma Research and Development, LLC | 2017 | — | Designated |
Brentuximab vedotin | Brentuximab vedotin | Seagen Inc. | 2017 | — | Designated |
liposomal vinorelbine | liposomal vinorelbine | Taiwan Liposome Company, Ltd. | 2016 | — | Designated |
doxorubicin | doxorubicin | Louis D. Falo, Jr. | 2015 | — | Designated |
A-dmDT390-bisFv(UCHT1) | A-dmDT390-bisFv(UCHT1) | Angimmune, LLC | 2014 | — | Designated |
methylparaben suberohydroxamic acid phenyl ester | methylparaben suberohydroxamic acid phenyl ester | Biossil Inc. | 2013 | — | Designated |
hydralazine - magnesium valproate | hydralazine - magnesium valproate | Neolpharma S.A.DE C.V. | 2011 | — | Designated |
Panobinostat | Panobinostat | Novartis Pharmaceuticals Corporation | 2007 | — | Withdrawn |
N-[4-(4-amino-2-ethyl-lH-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide | N-[4-(4-amino-2-ethyl-lH-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide | Pfizer, Inc. | 2006 | — | Withdrawn |
hypericin | hypericin | Soligenix, Inc. | 2000 | — | Designated |
Pentostatin | Pentostatin | SuperGen, Inc. | 1998 | — | Designated |
Facilitated DNA Plasmid Vaccine | Facilitated DNA Plasmid Vaccine | Wyeth-Lederle Vaccines and Pediatrics | 1995 | — | Designated |
Ricin (blocked) conjugated murine monoclonal antibody (CD6) | Ricin (blocked) conjugated murine monoclonal antibody (CD6) | ImmunoGen, Inc. | 1994 | — | Withdrawn |
Peldesine | Peldesine | BioCryst Pharmaceuticals, Inc. | 1993 | — | Designated |
Interferon beta (recombinant) | Interferon beta (recombinant) | Biogen, Inc. | 1991 | — | Withdrawn |
